FDA Inspection 910286 — Padagis Israel Pharmaceuticals Ltd.

Padagis Israel Pharmaceuticals Ltd. — FEI 3001904238

The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on Jan 22, 2015 in Yerucham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 22, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yerucham (Israel)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.